CompletedNot Applicable

Reflective Function as a Mediator of Interpersonal Psychotherapy (IPT)

United States29 participantsStarted 2016-04

Plain-language summary

Our recent randomized controlled trial of psychotherapies for posttraumatic stress disorder (PTSD) showed that Interpersonal Psychotherapy (IPT) benefitted patients. The mechanism of action for IPT is unclear; unlike most PTSD therapies, it does not work through exposure to trauma reminders. This assessment study will assess Symptom-Specific Reflective Function, a measure of emotional awareness of one's PTSD symptoms, as a potential mediator of IPT, capitalizing on naturalistic treatment of military veterans with PTSD at Columbia University/New York State Psychiatric Institute.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age 18 and older History
✓. Primary diagnosis of DSM-5 PTSD Clinical interview: CAPS-5
✓. Significant distress affecting social/ occupational functioning Clinical interview, self-report measures PHQ-9, GAD-7, PCL-5, DRRI-2
✓. Prior military service (for veteran) or significant relationship with individual with prior military service (for family member) History
✓. Able to give consent, fluent in English or Spanish Clinical assessment

Exclusion criteria

✕. History of Axis I psychiatric diagnosis of psychotic disorder, bipolar disorder, antisocial personality disorder Clinical assessment
✕. Unstable or life threatening medical condition Clinical assessment
✕. Acute suicide or homicide risk Clinical assessment

What they're measuring

Clinician-Administered PTSD Scale for DSM-5 (CAPS-5)

Timeframe: 14 weeks

Trial details

NCT IDNCT02645929

SponsorNew York State Psychiatric Institute

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-04-30

View on ClinicalTrials.gov More PTSD trials